These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33264437)

  • 1. Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis.
    Kim SS; Eun JW; Cho HJ; Song DS; Kim CW; Kim YS; Lee SW; Kim YK; Yang J; Choi J; Yim HJ; Cheong JY
    Aliment Pharmacol Ther; 2021 Feb; 53(4):540-551. PubMed ID: 33264437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients.
    Lang S; Fairfied B; Gao B; Duan Y; Zhang X; Fouts DE; Schnabl B
    Gut Microbes; 2020 Nov; 12(1):1785251. PubMed ID: 32684075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of gut microbiome in autoimmune hepatitis.
    Wei Y; Li Y; Yan L; Sun C; Miao Q; Wang Q; Xiao X; Lian M; Li B; Chen Y; Zhang J; Li Y; Huang B; Li Y; Cao Q; Fan Z; Chen X; Fang JY; Gershwin ME; Tang R; Ma X
    Gut; 2020 Mar; 69(3):569-577. PubMed ID: 31201284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifaximin prevents ethanol-induced liver injury in obese KK-A
    Kitagawa R; Kon K; Uchiyama A; Arai K; Yamashina S; Kuwahara-Arai K; Kirikae T; Ueno T; Ikejima K
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G707-G715. PubMed ID: 31509430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.
    Abe K; Takahashi A; Fujita M; Imaizumi H; Hayashi M; Okai K; Ohira H
    PLoS One; 2018; 13(7):e0198757. PubMed ID: 29969462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH.
    Loomba R; Ling L; Dinh DM; DePaoli AM; Lieu HD; Harrison SA; Sanyal AJ
    Hepatology; 2021 Jan; 73(1):126-143. PubMed ID: 32794259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH).
    Jiménez C; Ventura-Cots M; Sala M; Calafat M; Garcia-Retortillo M; Cirera I; Cañete N; Soriano G; Poca M; Simón-Talero M; Altamirano J; Lucey M; Garcia-Tsao G; Brown RS; Schwabe RF; Verna EC; Schnabl B; Bosques-Padilla F; Mathurin P; Caballería J; Louvet A; Shawcross DL; Abraldes JG; Genescà J; Bataller R; Vargas V
    Liver Int; 2022 May; 42(5):1109-1120. PubMed ID: 35220659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation.
    Chen X; Li P; Liu M; Zheng H; He Y; Chen MX; Tang W; Yue X; Huang Y; Zhuang L; Wang Z; Zhong M; Ke G; Hu H; Feng Y; Chen Y; Yu Y; Zhou H; Huang L
    Gut; 2020 Mar; 69(3):513-522. PubMed ID: 31900289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preterm Birth Is Correlated With Increased Oral Originated Microbiome in the Gut.
    Yin C; Chen J; Wu X; Liu Y; He Q; Cao Y; Huang YE; Liu S
    Front Cell Infect Microbiol; 2021; 11():579766. PubMed ID: 34222033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
    Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and Future Biomarkers in Alcoholic Hepatitis.
    Rutledge SM; Im GY
    Clin Liver Dis; 2021 Aug; 25(3):493-516. PubMed ID: 34229836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
    Jørgensen SF; Macpherson ME; Bjørnetrø T; Holm K; Kummen M; Rashidi A; Michelsen AE; Lekva T; Halvorsen B; Trøseid M; Mollnes TE; Berge RK; Yndestad A; Ueland T; Karlsen TH; Aukrust P; Hov JR; Fevang B
    Sci Rep; 2019 Jan; 9(1):167. PubMed ID: 30655568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus.
    Sun X; Chi X; Zhao Y; Liu S; Xing H
    J Diabetes Res; 2022; 2022():1826181. PubMed ID: 35601017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.
    Kimer N; Meldgaard M; Hamberg O; Kronborg TM; Lund AM; Møller HJ; Bendtsen F; Ytting H
    PLoS One; 2022; 17(3):e0264278. PubMed ID: 35286322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
    Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
    Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial.
    Madsen BS; Trebicka J; Thiele M; Israelsen M; Arumugan M; Havelund T; Krag A
    Trials; 2018 Feb; 19(1):143. PubMed ID: 29482588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Virome in Patients With Alcoholic Hepatitis.
    Jiang L; Lang S; Duan Y; Zhang X; Gao B; Chopyk J; Schwanemann LK; Ventura-Cots M; Bataller R; Bosques-Padilla F; Verna EC; Abraldes JG; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross DL; Ho SB; Louvet A; Lucey MR; Mathurin P; Garcia-Tsao G; Kisseleva T; Brenner DA; Tu XM; Stärkel P; Pride D; Fouts DE; Schnabl B
    Hepatology; 2020 Dec; 72(6):2182-2196. PubMed ID: 32654263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxonomic and Functional Compositions of the Small Intestinal Microbiome in Neonatal Calves Provide a Framework for Understanding Early Life Gut Health.
    Malmuthuge N; Liang G; Griebel PJ; Guan LL
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30658973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.